These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 18496893
1. Evaluation of at-home phlebotomy for iron overload: feasibility and satisfaction of patients and healthcare workers. Manea P, Loustaud-Ratti V, Mondary D, Arnold V, Ferley JP, Souris S, Fauchais AL, Liozon E, Vidal E. Gastroenterol Clin Biol; 2008 Feb; 32(2):172-9. PubMed ID: 18496893 [Abstract] [Full Text] [Related]
2. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors. Majhail NS, Lazarus HM, Burns LJ. Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863 [Abstract] [Full Text] [Related]
3. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia. Franchini M, Gandini G, Veneri D, de Matteis G, Federici F, Solero P, Aprili G. Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247 [Abstract] [Full Text] [Related]
4. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Hicken BL, Tucker DC, Barton JC. Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790 [Abstract] [Full Text] [Related]
5. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A. Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730 [Abstract] [Full Text] [Related]
6. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations]. Fernández-Mosteirín N, Salvador-Osuna C, García-Erce JA, Orna E, Pérez-Lungmus G, Giralt M. Med Clin (Barc); 2006 Sep 23; 127(11):409-12. PubMed ID: 17020684 [Abstract] [Full Text] [Related]
7. A prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT. Kew AK, Clarke S, Ridler A, Burrell S, Edwards JA, Doucette S, Couban S. Bone Marrow Transplant; 2015 Mar 23; 50(3):457-8. PubMed ID: 25501351 [No Abstract] [Full Text] [Related]
8. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy. Brigant F, Hautefeuille V, Dadban A, Lok C, Nguyen-Khac E, Chaby G. Dermatol Online J; 2015 Sep 17; 21(9):. PubMed ID: 26437295 [Abstract] [Full Text] [Related]
9. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload. Aygun B, Mortier NA, Kesler K, Lockhart A, Schultz WH, Cohen AR, Alvarez O, Rogers ZR, Kwiatkowski JL, Miller ST, Sylvestre P, Iyer R, Lane PA, Ware RE, Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) Trial Investigators. Br J Haematol; 2015 Apr 17; 169(2):262-6. PubMed ID: 25612463 [Abstract] [Full Text] [Related]
10. [Predictive factors of response to erytrhocytapheresis in patients with biochemical iron overload with or without hereditary hemochromatosis type 1]. Parra Salinas I, Montes Limon A, Recasens Flores V, Fernandez-Mosteirin N, Garcia-Erce JA. Med Clin (Barc); 2014 Mar 04; 142(5):187-91. PubMed ID: 24041941 [Abstract] [Full Text] [Related]
11. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions. Pack-Mabien A, Brown B, Herbert DE, Haynes J. J Am Assoc Nurse Pract; 2015 Oct 04; 27(10):591-6. PubMed ID: 25711464 [Abstract] [Full Text] [Related]
12. Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome. Bardou-Jacquet E, Lainé F, Morcet J, Perrin M, Guyader D, Deugnier Y. Eur J Gastroenterol Hepatol; 2014 Apr 04; 26(4):418-21. PubMed ID: 24557330 [Abstract] [Full Text] [Related]
13. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Casanova-Esteban P, Guiral N, Andrés E, Gonzalvo C, Mateo-Gallego R, Giraldo P, Paramo JA, Civeira F. Metabolism; 2011 Jun 04; 60(6):830-4. PubMed ID: 20846699 [Abstract] [Full Text] [Related]
14. Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: results from a randomized, controlled trial on 40 Japanese patients. Sumida Y, Kanemasa K, Fukumoto K, Yoshida N, Sakai K. Intern Med; 2007 Jun 04; 46(10):637-42. PubMed ID: 17527035 [Abstract] [Full Text] [Related]
15. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial. Lainé F, Reymann JM, Morel F, Langouët S, Perrin M, Guillygomarc'h A, Brissot P, Turmel V, Mouchel C, Pape D, Bellissant E, Deugnier Y. Aliment Pharmacol Ther; 2006 Oct 15; 24(8):1207-13. PubMed ID: 17014579 [Abstract] [Full Text] [Related]
16. Which physicians make home visits and why? A survey. Bergeron R, Laberge A, Vézina L, Aubin M. CMAJ; 1999 Aug 24; 161(4):369-73. PubMed ID: 10478159 [Abstract] [Full Text] [Related]
17. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Lainé F, Ruivard M, Loustaud-Ratti V, Bonnet F, Calès P, Bardou-Jacquet E, Sacher-Huvelin S, Causse X, Beusnel C, Renault A, Bellissant E, Deugnier Y, Study Group. Hepatology; 2017 Feb 24; 65(2):465-474. PubMed ID: 27685251 [Abstract] [Full Text] [Related]
18. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes. Mifuji-Moroka R, Iwasa M, Miyachi H, Sugimoto R, Tanaka H, Ishihara T, Fujita N, Kaito M, Kobayashi Y, Takei Y. Hepatogastroenterology; 2013 Oct 24; 60(127):1736-41. PubMed ID: 24634944 [Abstract] [Full Text] [Related]
19. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Barton JC, Preston BL, McDonnell SM, Rothenberg BE. Transfusion; 2001 Jan 24; 41(1):123-9. PubMed ID: 11161257 [Abstract] [Full Text] [Related]
20. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation. Inati A, Kahale M, Sbeiti N, Cappellini MD, Taher AT, Koussa S, Nasr TA, Musallam KM, Abbas HA, Porter JB. Pediatr Blood Cancer; 2017 Jan 24; 64(1):188-196. PubMed ID: 27576370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]